Neuronal alterations in AKT isotype expression in schizophrenia
Robert E. McCullumsmith(Neurosciences Institute), Emily A. Devine(University of Cincinnati), William G. Ryan(University of Toledo), Sinead M. O’Donovan(University of Toledo), Hunter Eby(University of Toledo), Consuelo Walss‐Bass(The University of Texas Health Science Center at Houston), Ali Sajid Imami(University of Toledo), Taylen Arvay(University of Toledo), Elizabeth Shedroff(University of Toledo), Alex Joyce(University of Toledo), Abdul‐rizaq Hamoud(ProMedica Toledo Hospital), Sophie M. Asah(University of Toledo), Smita Sahay(University of Toledo), Hasti Golchin(University of Toledo)
Cited by 2
Related Papers
Bilirubin in the Liver–Gut Signaling Axis
|Trends in Endocrinology and Metabolism|2018|254
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
|Neuropsychopharmacology|2013|120
Biliverdin reductase and bilirubin in hepatic disease
|American Journal of Physiology-Gastrointestinal and Liver Physiology|2018|100
Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α
|Journal of Biological Chemistry|2020|97
Signature-based approaches for informed drug repurposing: targeting CNS disorders
|Neuropsychopharmacology|2020|68